• Scimedico

CSU secures award for development of SolaVAX vaccine manufacturing process for #COVID19

A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to further develop a novel virus inactivation process, successfully used for MERS, which has the potential to inactivate the #COVID19 virus.

Click HERE for the full story.

1 view
  • LinkedIn - Black Circle
  • Facebook - Black Circle
  • Twitter - Black Circle

Find It Fast

Scimedico L.L.C.

T: 908.986.3000 

F: 480.275.3317

E: info@scimedico.com

Mailing:

623 Eagle Rock Avenue 

West Orange, NJ 07052

Headquarters:

210 Bellevue Avenue

Montclair, NJ 07043

© 2020 Scimedico, LLC